Synthesis and testing of a triaza-cyclopenta[b]phenanthrene scaffold as a DNA binding agent
Authors:
- Steven M. FirestineSFSteven M. Firestine
- 1 March 2006
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (6) , 1902-1909
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: Further evidence for the inflammatory basis of atherosclerosisAmerican Heart Journal, 2005
- Programmable DNA Binding Oligomers for Control of TranscriptionCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- Toward transcriptional therapies for the failing heart: chemical screens to modulate genesJournal of Clinical Investigation, 2005
- Transcriptional down-regulation of neurotrophin-3 in chronic obstructive pulmonary diseaseBiological Chemistry, 2005
- Transcriptional profiling and drug discoveryCurrent Opinion in Pharmacology, 2003
- Transcription factors as targets for cancer therapyNature Reviews Cancer, 2002
- Therapeutic modulation of transcription factor activityTrends in Pharmacological Sciences, 2001
- The therapeutic potential of targeting drugs at transcription factorsExpert Opinion on Investigational Drugs, 1999
- Oncogenes and Transcriptional ControlScience, 1987
- Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.Proceedings of the National Academy of Sciences, 1984